Pharmafile Logo
Pharmafocus logo
Advanced Search
dna-g009a668c7_1280

Evonetix commences access programme for synthesised DNA

August 17, 2022
Research and Development

Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Evonetix has announced the opening …

News

Lynparza combination therapy gets FDA priority review for prostate cancer

August 17, 2022
Research and Development

Lynparza is being jointly developed by UK-based AstraZeneca and MSD AstraZeneca’s supplemental new drug application for Lynparza (olaparib) in combination …

News
surgery-1822458_960_720

Successful study to change the blood type of donor kidneys means access for more BAME recipients

August 17, 2022
Research and Development

Scientists at the University of Cambridge have successfully altered the blood type of donor kidneys in a study which could …

News
istockphoto-1266494637-170667a

Patient with HNSCC dosed with triple combination therapy in Phase II of Genexine clinical trial

August 17, 2022
Research and Development

Genexine, a South Korean clinical-staged biopharmaceutical company, have announced the dosing with triple combination therapy of the first patient with …

News

Santen launches Ducressa for post-cataract surgery

August 16, 2022
Manufacturing and Production

Treatment involves a combination of levofloxacin and dexamethasone for use after cataract surgery Santen has announced the launch of Ducressa …

News

The impact of COVID-19 on the fight against AMR

August 16, 2022
Manufacturing and Production

How the responses to the COVID-19 pandemic have affected antibiotic-resistant bacteria   Responses to the COVID-19 pandemic may have impacted …

News

BrainStorm’s ALS-combatting drug finally on its way to the FDA

August 16, 2022
Manufacturing and Production

BrainStorm Cell Therapeutics’ NurOne was rejected by the Food and Drug Association in February 2021 but this year, after consulting …

News

UK first country to approve bivalent booster which targets both original COVID-19 as well as the Omicron strain

August 16, 2022
Manufacturing and Production

The UK medicines regulator (MHRA) has given the Moderna-made vaccine conditional approval, backed up by the Joint Committee on Vaccination …

News

Sanofi and NIHR enrol first patient in immunisation study for RSV in infants

August 15, 2022
Sales and Marketing

The European study will evaluate the use of the human recombinant monoclonal antibody nirsevimab   Sanofi and the National Institute …

News

NHS England outlines measures to boost capacity ahead of substantial winter pressures

August 15, 2022
Sales and Marketing

The package of measures includes creating the equivalent of 7,000 additional hospital beds   NHS England has announced a package …

News

Focused ultrasound therapies could be made more affordable by 3D-printed acoustic holograms to help overcome the blood-brain barrier

August 15, 2022
Sales and Marketing

The 3D-printed acoustic hologram is used with focused ultrasound (FUS) to create a more controlled and precise opening in the …

News
brain_fgo

Cognitive rehabilitation therapy may help older adults clear COVID-19-related brain fog

August 15, 2022
Sales and Marketing

Medical centres in the US have started referring older patients with long COVID-19-related symptoms for cognitive rehabilitation in order to …

News

MHRA grants marketing authorisation for Novartis’ Pluvicto

August 12, 2022
Medical Communications

Radioligand therapy is used to treat patients with advanced prostate cancer

News

Bristol Myers Squibb and GentiBio in $1.9bn deal to develop inflammatory bowel disease therapies

August 12, 2022
Medical Communications

BMS will have the right to develop and advance up to three of the resulting programmes into clinical trials

News
blood_tests_pic

Blood tests taken within 24 hours of a traumatic brain injury can predict whether a patient will die, or survive with serious disability

August 12, 2022
Medical Communications

The tests’ results are available within minutes and will be useful in helping trauma ward staff and surgeons to decide …

News
booster

ONS figures show rapid decrease in people with higher COVID-19 antibody figures

August 12, 2022
Medical Communications

The amount of UK residents with higher levels of COVID-19 antibodies is falling, ONS statistics show.

News

Pfizer to buy Global Blood Therapeutics for $5.4bn

August 11, 2022
Business Services

Pfizer Inc is to pay $5.4 billion in cash to acquire sickle cell disease drug-maker Global Blood Therapeutics, according to …

News

All children aged one to nine in London to be offered polio vaccine

August 11, 2022
Business Services

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that a targeted inactivated polio vaccine (IPV) booster be given …

News
hospital-1802680__340

NHS backlog of 22,500 longest-wait patients slashed to fewer than 200, says NHS England figures

August 11, 2022
Business Services

The COVID-19 pandemic caused a huge backlog in patients as medical services focused their efforts on combating the virus. At …

News

COVID-19 sewage surveillance labs join the hunt for monkeypox

August 11, 2022
Business Services

Wastewater surveillance techniques are being adapted for use in monitoring the spread of monkeypox across the San Francisco Bay Area …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026